Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-10-08
1999-04-20
Reamer, James H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31405
Patent
active
058957871
ABSTRACT:
A method of treating fibromyalgia-like complaints (i.e., fibromyalgia, chronic fatigue syndrome and irritable bowel syndrome) in a patient, the method comprising: administering to the patient an 1H-indole-3-methanol compound (e.g., 1H-indole-3-methanol, ascorbigen, bis(3-indolyl) methane, 1H-indol-3-yl methoxy methane, ethoxy 1H-indol-3-yl ethoxy methane, other ethers of 1H-indole-3-methanol) in a medically acceptable manner in a pharmaceutically effective amount on a regular basis. It has been found that the administration of such indoles, particularly, 1H-indole-3-methanol, greatly mitigates the most severe symptoms of fibromyalgia. Patients with fibromyalgia have reported a decrease in pain, less fatigue, improved sleep patterns, and an improved sense of well being resulting from the oral administration of pharmaceutically effective amounts of an 1H-indole-3-methanol compound each day.
REFERENCES:
patent: 4428962 (1984-01-01), Bristol et al.
patent: 4877798 (1989-10-01), Sorensen
patent: 5314908 (1994-05-01), McAfee
patent: 5641800 (1997-06-01), Bach et al.
patent: 5707642 (1998-01-01), Yue
Bennett, Robert, "Fibromyalgia and the Disability Dilemma", Arthritis & Rheumatism, vol. 39, No. 10, pp. 1627-1634, Oct. 1996.
Carette, Simon, "Fibromyalgia 20 years later: What Have We Really Accomplished?", The Journal of Rheumatology, 22:4, pp. 590-594, 1995.
Designed Nutritional Products, "Product Information", 1 sheet, Mar. 1, 1997.
Hadler, Nortin M., "If You Have to Prove You Are Ill, You Can't Get Well", Spine, vol. 21, No. 20, pp. 2397-2400, 1996.
Life Plus Foundation, "Relief From Chronic Fatigue Syndrome", Internet web site information, 7 pages, Jul. 9, 1997.
Michnovicz et al., "Changes in Levels of Urinary Estrogen Metabolites After Oral Indole-3-Carbinol Treatment in Humans", Journal of the National Cancer Institute, vol. 89, No. 10, pp. 718-723, May 21, 1997.
Michnovicz et al., "Dietary Cytochrome P-450 Modifiers in the Control of Estrogen Metabolism", Food Phytochemicals I: Fruits and Vegetables, pp. 282-293.
Nye, David A., "Fibromyaigia -- a guide for patients", Sapient Health Network, 7 pages, Aug. 13, 1995.
Nye, David A., "Fibromyaigia -- A Physician's Guide", Sapient Health Network, 9 pages, 1995.
Physical Medicine Research Foundation, "The Fibromyalgia Syndrome: A Consensus Report on Fibromyalgia and Disability", The Journal of Rheumatology, 23:3, pp. 534-539, 1996.
Romano et al., "Fibromyalgia 20 Years Later: What We Really Accomplished?", The Journal of Rheumatology, 23:1, pp. 192-194, 1996.
Thrive @ the healthy living experience, "Chronic Pain", 6 pages, 1996.
Wolfe et al., "Aspects of Fibromyalgia in the General Population: Sex, Pain Threshold, and Fibromyalgia Symptoms", The Journal of Rheumatology, 22:1, pp. 151-156, 1995.
Wolfe, Frederick, "Fibrositis, Fibromyalgia, and Musculoskeletal Disease: The Current Status of the Fibrositis Syndrome", Arch Phys Med Rehabil, vol. 69, pp. 527-531, Jul. 1988.
Wolfe et al., "The Prevalence and Characteristics of Fibromyalgia in the General Population", Arthritis & Rheumatism, vol. 38, No. 1, pp. 19-28, Jan. 1995.
Wolfe, Frederick, "When To Diagnose Fibromyalgia", Diagnostic Issues, vol. 20, No. 2, pp. 485-501, May 1994.
Andrus G. Merrill
Arffmann Kathleen
Designed Nutritional Products, Inc.
Reamer James H.
LandOfFree
Treatment of fibromyalgia and related disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of fibromyalgia and related disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of fibromyalgia and related disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2247979